The effects of inhibitors of PI3K/Akt/mTOR signaling have also been observed in neuroblastoma cells, which were treated using either the pan PI3K inhibitor LY294002 or the mTOR inhibitor rapamycin (46,47). Here, MTOR is linked to neuroblastoma.